Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H23N3O3S |
InChIKeyAFPMVLVIYVAFSP-UHFFFAOYSA-N |
CAS Registry1614225-93-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 14 Jun 2019 |